Related Experiment Video
Updated: Aug 11, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
Strategies for molecular intervention in esophageal cancers and their precursor lesions
1Thoracic Oncology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract:
Molecular analysis of malignant transformation in Barrett's epithelium provides insight into the temporal nature and significance of individual genetic events during multistep esophageal carcinogenesis. Potential targets for intervention in esophageal neoplasms include mutations involving retinoblastoma (Rb) and p53 tumor-suppressor pathways as well as tyrosine kinase cascades, which are known to promote cell cycle progression. Data from recent experiments provide the preclinical rationale for novel pharmacologic interventions in established esophageal cancers, and suggest strategies for chemoprevention in patients at risk for the development of these neoplasms.
Insights
Understanding genetic changes in Barrett's esophagus helps identify key events in esophageal cancer development. This research targets pathways like retinoblastoma (Rb) and p53 for new treatments and prevention strategies.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Barrett's esophagus is a precursor to esophageal adenocarcinoma.
- Multistep carcinogenesis involves accumulating genetic alterations.
- Understanding these alterations is crucial for targeted therapies.
Purpose of the Study:
- To elucidate the molecular mechanisms of malignant transformation in Barrett's epithelium.
- To identify critical genetic events in multistep esophageal carcinogenesis.
- To provide a basis for novel therapeutic and chemopreventive strategies.
Main Methods:
- Molecular analysis of genetic events in Barrett's epithelium.
- Investigation of tumor-suppressor pathways (e.g., retinoblastoma, p53).
- Analysis of tyrosine kinase cascades involved in cell cycle progression.
Main Results:
- Identified the temporal sequence and significance of genetic events.
- Highlighted the role of Rb and p53 pathway mutations.
- Demonstrated the involvement of tyrosine kinase signaling in esophageal neoplasms.
Conclusions:
- Molecular insights into Barrett's esophagus aid in understanding esophageal cancer progression.
- Targeting specific genetic pathways (Rb, p53, tyrosine kinases) offers therapeutic potential.
- Findings support the development of pharmacologic interventions and chemoprevention for at-risk patients.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...

